Proton pump inhibitors for Barrett's oesophagus.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it.

1. Treatment for Barrett's oesophagus.The Cochrane database of systematic reviews · 2010
   Pooled it
2. Incidence rates of Barrett's esophagus and esophageal adenocarcinoma: a systematic review and meta-analysis.iGIE : innovation, investigation and insights · 2024
   Article
3. Melatonin in Prevention of the Sequence from Reflux Esophagitis to Barrett's Esophagus and Esophageal Adenocarcinoma: Experimental and Clinical Perspectives.International journal of molecular sciences · 2018
   Review
4. Adult and paediatric GERD: diagnosis, phenotypes and avoidance of excess treatments.Nature reviews. Gastroenterology & hepatology · 2016
   Review
5. Proton pump inhibitors and vascular function: A prospective cross-over pilot study.Vascular medicine (London, England) · 2015
   Article
6. The Role of Gastroesophageal Reflux and Other Factors during Progression to Esophageal Adenocarcinoma.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2015
   Article
7. Effect of alpha-tocopherol, N-acetylcysteine and omeprazole on esophageal adenocarcinoma formation in a rat surgical model.International journal of cancer · 2009
   Article
8. The role of proton pump inhibitors in gastro-oesophageal reflux disease.Drugs · 2004
   Review
9. Surveillance in Barrett's oesophagus: a personal view.Postgraduate medical journal · 2002
   Review
10. Bile reflux gastritis and Barrett's oesophagus: further evidence of a role for duodenogastro-oesophageal reflux?Gut · 2001
    Article
11. Dysplasia in Barrett's Esophagus.Current treatment options in gastroenterology · 2001
    Article

Corrections and comments

• Erratum issued
  Proton pump inhibitors for Barrett's oesophagus.2000

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as